Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308763 · ClinicalTrials.gov registry record · NA
Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 594
- Enrollment target
NCT00308763 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 594 participants.
The verdict
NCT00308763, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 594 participants
- Enrollment target
Study Summary
Nicotine addiction is a serious health problem in the United States; 46 million people smoke cigarettes, and 70% of those are trying to quit. The nicotine patch and bupropion, a medication used to reduce nicotine cravings, are two commonly used smoking cessation aids. Both have been shown to reduce smoking rates, however, the effectiveness of combining the two treatments has not been widely examined. This study will evaluate the effectiveness of the nicotine patch combined with bupropion at reducing smoking rates among younger, low-income, and minority individuals.
Interventions
- DRUG Nicotine Patch
- DRUG Sustained Release Bupropion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 594 participants |
| Start Date | 2004-01 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00308763
The ClinicalTrials.gov registry entry for NCT00308763 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 594 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicotine Patch is the first listed.
NCT00308763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00308763 about?
NCT00308763 is a clinical study titled "Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals". Nicotine addiction is a serious health problem in the United States; 46 million people smoke cigarettes, and 70% of those are trying to quit. The nicotine patch and bupropion, a medication used to reduce nicotine cravings, are two commonly used smoking cessation aids. Both have been shown to reduce ...
What is the current status of trial NCT00308763?
This trial is currently completed. It is a NA study. The enrollment target is 594 participants. The study started on 2004-01. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00308763?
The interventions under investigation include: Nicotine Patch (DRUG), Sustained Release Bupropion (DRUG).
Who is sponsoring clinical trial NCT00308763?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.